BlackRock Institutional Trust’s Cardiff Oncology CRDF Stock Holding History

BlackRock Institutional Trust’s Portfolio CRDF Stock Details CRDF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.38M	Hold	9,126	–	–	﹤0.01%	3187
2016 Q3	$2.95M	Sell	9,126 -4	-0%	-$1.46K	﹤0.01%	2909
2016 Q2	$2.98M	Sell	9,130 -46	-0.5%	-$15.8K	﹤0.01%	2891
2016 Q1	$3.07M	Buy	9,176 +557	+6%	+$190K	﹤0.01%	2870
2015 Q4	$3.35M	Buy	8,619 +1,210	+16%	+$474K	﹤0.01%	2905
2015 Q3	$3.04M	Buy	7,409 +4,711	+175%	+$2.47M	﹤0.01%	2941
2015 Q2	$1.97M	Buy	2,698 +2,581	+2,206%	+$1.83M	﹤0.01%	3125
2015 Q1	$57K	Buy	117 +85	+266%	+$36.3K	﹤0.01%	3746
2014 Q4	$10K	Buy	+32	New	+$10.4K	﹤0.01%	3858
2013 Q3	–	Sell	-60	Closed	-$30K	–	3955
2013 Q2	$30K	Buy	+60	New	+$27.1K	﹤0.01%	3849

Other funds holding CRDF

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PFS

Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

BlackRock Institutional Trust's CRDF Position: Q4 2016 in Review

BlackRock Institutional Trust held its Cardiff Oncology (CRDF) position steady in Q4 2016 at 9,126 shares worth $1.38M. The position accounts for ﹤0.01% of the portfolio, ranked #3187.

BlackRock Institutional Trust first reported a position in CRDF in Q2 2013 and has held it in 10 quarters since. The position peaked at $3.35M in Q4 2015. 68 funds tracked by Wall St. Rank hold CRDF as of Q4 2016.

BlackRock Institutional Trust held 9,126 shares of Cardiff Oncology worth $1.38M as of Q4 2016.
BlackRock Institutional Trust left its Cardiff Oncology share count unchanged in Q4 2016.
Cardiff Oncology made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3187 holding.
BlackRock Institutional Trust first reported a position in Cardiff Oncology in Q2 2013 and has held it in 10 quarters since.
BlackRock Institutional Trust's Cardiff Oncology position peaked at $3.35M in Q4 2015.
68 funds tracked by Wall St. Rank held Cardiff Oncology as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.